6 September 2019

EATRIS, the European infrastructure for translational medicine, obtained funding for a new flagship project for sustainability and personalised medicine: EATRIS-Plus. Alain van Gool (LabGK), Peter-Bram ‘t Hoen (CMBI) and Ariaan Siezen (IM) are co-PI’s and receive approximately 550 k€ from this 5M€ Horizon2020 infrastructure development grant.

The project aims to build further capabilities and deliver innovative scientific tools to support the long-term sustainability of EATRIS. A key output of the project will be the piloting and delivery of a multi-omic toolbox, that will include SOPs, guidelines for best practices, reference materials, quality parameters, analysis tools, criteria for establishing reference values, and will provide access to a repository of multi-omic data. Objectives that are in line with the ambitions of the Netherlands X-omics Initiative, coordinated by Van Gool.

EATRIS covers over 90 institutes across Europe, among which Radboudumc. It has shown strong proof of concept of the value and utility of its translational medicine services portfolio, with users including academia, SMEs, large pharma, biotech and research funding organisations. The overarching aim of EATRIS-Plus is to further support the long-term sustainability of EATRIS by delivering innovative scientific tools to the personalised medicine research community. EATRIS-Plus will help pooling and utilising the translational academic capacities of the infrastructure in omics technologies to enable researchers to better address the scientific and societal challenges of personalised medicine.

More information: link. 

Related news items


Jong KNCV organizes a Pitch competition for PhD candidates

13 August 2020

Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.

read more

Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels

13 August 2020

Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.

read more

TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer

12 August 2020

An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.

read more

BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea

11 August 2020

The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

read more

ERC Proof of Concept grant received by Ronald van Rij

30 July 2020

Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more